News and Policies
Jiangsu cooperates with UK biopharma company in medical IoT
Updated: Aug 18, 2017
chinadaily.com.cn
Print
Share - WeChat
 |
| Li Qiang, Party secretary of Jiangsu, meets with Pascal Soriot, CEO of AstraZeneca on Aug 15 in Nanjing, capital of Jiangsu province. [Photo/ jstv.com] |
Jiangsu province will continue to deepen its cooperation with UK-based biopharma company AstraZeneca in biological medicine and medical internet of things.
The news was announced at a meeting between Li Qiang, Party secretary of Jiangsu province, and Pascal Soriot, CEO of AstraZeneca in Nanjing, capital of Jiangsu province on Aug 15.
After introducing Jiangsu's economic and social development conditions, Li said that the province boasts a sound manufacturing industry, an open economy, sufficient talent resources, and a good foundation and conditions for developing its medical industry.
He added that the biomedical industry is a promising high-tech industry and is also one of the key emerging industries in Jiangsu.
MOST POPULAR
- 1 $39.7 billion worth of deals inked at Airshow China
- 2 China announces tax relief measures to stabilize real estate sector
- 3 A look at China's economy in October, 2024
- 4 Public holiday extension announced
- 5 China's NEV annual production hits 10 million milestone amid global carbon reduction efforts
Editors' Picks
Infographic:
Golden jubilee of China-Brazil relations
Infographic:
A look at China's economy in October 2024
